CCO Podcasts
Regional Therapy for HCC: Patient Selection and Management Issues
|
|
Melanie B. Thomas MD, MS, and other expert CCO expert faculty members review and explore regional treatment strategies for the clinical management of patients with HCChepatocellular carcinoma.
Date posted: 2/24/2009
| Duration: 30:42
|
Systemic Therapy and Multidisciplinary Supportive Care in Patients With Advanced HCC
|
|
Alan P. Venook, MD, and other CCO expert faculty members discuss systemic treatment options for the clinical management of patients with hepatocellular carcinoma.
Date posted: 2/24/2009
| Duration: 24:27
|
Expert Highlight: Gastrointestinal Cancers
|
|
Date posted: 12/31/2008
| Duration: 8:56
|
Expert Highlight: Lung Cancer
Expert Highlight: Hematologic Malignancies
|
|
Date posted: 12/31/2008
| Duration: 5:29
|
Expert Highlight: Breast Cancer
|
|
Kathy D. Miller, MD, provides an update on the top issues in adjuvant therapy including hormone therapy, bone loss treatments, and vitamin D status. She also discusses the impact of biologic agents targeting VEGF and EGFR on therapy for metastatic disease. (12 minutes)
Date posted: 12/31/2008
| Duration: 12:03
|
Expert Highlight: Genitourinary Cancers
|
|
Date posted: 12/31/2008
| Duration: 7:52
|
Expert Highlight: Acute Leukemias and Myelodysplastic Syndromes
|
|
Hagop Kantarjian, MD, provides an update of presentations on acute myeloid leukemia, myelodysplastic syndromes, and myelofibrosis.
Date posted: 12/13/2008
| Duration: 9:16
|
Updates in CLL
|
|
Kanti Rai, MD, discusses updates in CLL therapies, including lenalidomide in the frontline setting, FCR data from the REACH trial, and the novel agent ofatumumab.
Date posted: 12/13/2008
| Duration: 12:49
|
Expert Highlight: ESAs in Cancer
|
|
David P. Steensma, MD, describes a patient-level meta-analysis on the effect of ESAs on the survival of cancer patients and the implications for patient care.
Date posted: 12/13/2008
| Duration: 8:29
|
Expert Highlight: Lymphomas
|
|
Steven Bernstein, MD, summarizes the clinical advances in improving outcomes in patients with non-Hodgkin’s lymphomas, in particular T-cell lymphomas and mantle cell lymphomas.
Date posted: 12/12/2008
| Duration: 7:13
|
Updates Multiple Myeloma
|
|
Date posted: 12/11/2008
| Duration: 5:14
|
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
|
Featured Content
Review CE-certified activities selected for the ongoing educational needs of oncology nurses.
Visit CCO Oncology inPractice today for quick answers to everyday treatment questions.
Increase your understanding of the key studies from the 2009 Breast Cancer Symposium.
Increase your understanding of bone health issues in the treatment of breast cancer.
|
|